Better, not more CM regulation: ASMI

ASMI has urged the Federal Government to fine-tune the regulatory system for complementary medicines, calling for better rather than less regulation of complementary medicines. Dr Deon Schoombie, ASMI Executive Director, says ASMI’s submission to the complementary medicines section of the Federal Government’s Review of Medicines and Medical Devices Regulation advocates for a best practice risk-based